• DOI:10.1007/s40263-013-0084-8
Corpus ID: 40931380

Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management

@article{Spiller2013OverdoseOD,
  title={Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management},
  author={H. Spiller and Hannah L. Hays and A. Aleguas},
  journal={CNS Drugs},
  year={2013},
  volume={27},
  pages={531-543}
}

• H. Spiller, Hannah L. Hays, A. Aleguas
• Published 2013
• Psychology, Medicine
• CNS Drugs

The prevalence of attention-deficit hyperactivity disorder (ADHD) in the USA is estimated at approximately 4–9 % in children and 4 % in adults. It is estimated that prescriptions for ADHD medications are written for more than 2.7 million children per year. In 2010, US poison centers reported 17,000 human exposures to ADHD medications, with 80 % occurring in children <19 years old and 20 % in adults. The drugs used for the treatment of ADHD are diverse but can be roughly separated into two… Expand

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed